Fractyl Health, Inc. Common Stock Cash Flow-to-Debt Ratio
Fractyl Health, Inc. Common Stock cash flow-to-debt ratio. Fractyl Health, Inc. Common Stock (GUTS) has a Cash Flow-to-Debt Ratio of -0.19x as of June 2026, meaning its operating cash flow of $-15.90 Million could theoretically repay 0% of its total liabilities ($83.64 Million) in one year. Check GUTS cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Fractyl Health, Inc. Common Stock (2019–2025)
Cash flow-to-debt ratio of Fractyl Health, Inc. Common Stock from 2019 to 2025. Historical debt coverage capacity for Fractyl Health, Inc. Common Stock across 7 annual periods. Also explore GUTS year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Fractyl Health, Inc. Common Stock Cash Flow-to-Debt Ratio by Year (2019–2025)
Fractyl Health, Inc. Common Stock cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Fractyl Health, Inc. Common Stock. For the full cash flow conversion analysis, see Fractyl Health, Inc. Common Stock (GUTS) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.81x | $-90.33 Million | $111.94 Million | ▲ +1.9% |
| 2024 | -0.82x | $-65.52 Million | $79.65 Million | ▼ -670.8% |
| 2023 | -0.11x | $-42.82 Million | $401.27 Million | ▲ +27.7% |
| 2022 | -0.15x | $-46.24 Million | $313.27 Million | ▼ -37.6% |
| 2021 | -0.11x | $-33.46 Million | $311.87 Million | ▲ +93.2% |
| 2020 | -1.57x | $-31.07 Million | $19.81 Million | ▼ -765.1% |
| 2019 | -0.18x | $-27.73 Million | $152.93 Million | — |